Charlotte Hamer says she watched her mum suffer when she was a child ...

A routine breast cancer screening gave Anabel Cano the all-clear, only for her to discover a year later that her tumor had ...

In November 2025, the U.S. Food and Drug Administration (FDA) issued several approvals across oncology and supportive care.

Knowledge is power, and it's also critical for making vital health care decisions. More information leads to better ...

Hellmann’s Mayonnaise will return to the Super Bowl for a sixth consecutive year with a 30-second spot handled by agency VML.

Lunit, a leading provider of AI for cancer diagnostics and precision oncology, today announced it will present 14 studies at ...

The bispecific HER2-directed antibody-drug conjugate (ADC) TQB2102 has demonstrated robust antitumor activity and a positive safety profile in the phase 2 TQB2102-II-01 trial (NCT06198751), showing ...

YUMA, Ariz. (KYMA) - As Breast Cancer Awareness Month comes to an end, we want to bring you a special story of one person with local ties currently fighting the disease. After years of seeking medical ...

Highest reported pathologic complete response rate seen in a phase 3 registrational trial for HER2 positive early breast cancer with favorable safety profile versus standard treatment DESTINY-Breast11 ...

The pathologic complete response rate was 53.8% with low-dose pembrolizumab plus chemotherapy and 40.5% with chemotherapy alone. In triple-negative breast cancer (TNBC), pembrolizumab at a tenth of ...

The procedure combines a mastectomy and reconstruction. When the results of her routine mammogram came back with a diagnosis of stage 0 DCIS breast cancer in multiple areas of her right breast, ...